Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO: An Alix fragm

Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO: An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J Biol Chem 2007, 282:3847–3855.Apoptosis inhibitor PubMedCrossRef 55. Schlundt A, Sticht J, Piotukh K, Kosslick D, Jahnke N, Keller S, Schuemann M, Krause E, Freund C: Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions. Mol Cell Proteomics 2009, 8:2474–2486.PubMedCrossRef 56. Demirov DG, Orenstein JM, Freed EO: The

late domain of human immunodeficiency virus type 1 p6 promotes virus release Staurosporine in a cell type-dependent manner. J Virol 2002, 76:105–117.PubMedCrossRef 57. Krieger E, Koraimann G, Vriend G: Increasing the precision of comparative models with YASARA

NOVA–a self-parameterizing force field. Proteins 2002, 47:393–402.PubMedCrossRef 58. Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH: Crystal structure of the West Nile virus envelope glycoprotein. J Virol 2006, 80:11467–11474.PubMedCrossRef 59. Kaufmann B, Vogt MR, Goudsmit J, Holdaway HA, Aksyuk AA, selleckchem Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG: Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354. Proc Natl Acad Sci USA 2010, 107:18950–18955.PubMedCrossRef 60. Pawliczek T, Crump CM: Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol 2009, 83:11254–11264.PubMedCrossRef

61. Irie T, Harty RN: L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. J Virol 2005, 79:12617–12622.PubMedCrossRef 62. Irie T, Licata JM, Jayakar HR, Whitt MA, Bell P, Harty RN: Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein. J Virol 2004, 78:7823–7827.PubMedCrossRef 63. Dowlatshahi DP, Sandrin V, Vivona S, Shaler TA, Kaiser SE, Melandri F, Sundquist WI, Kopito RR: ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding. Dev Cell 2012, 23:1247–1254.PubMedCrossRef 64. Keren-Kaplan T, Attali I, Estrin M, Kuo LS, Farkash E, Jerabek-Willemsen next M, Blutraich N, Artzi S, Peri A, Freed EO, et al.: Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding. The EMBO journal 2013, 32:538–551.PubMedCrossRef 65. Ko A, Lee EW, Yeh JY, Yang MR, Oh W, Moon JS, Song J: MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase. J Virol 2010, 84:426–436.PubMedCrossRef 66. Martin-Serrano J: The role of ubiquitin in retroviral egress. Traffic 2007, 8:1297–1303.PubMedCrossRef 67. Ng ML, Howe J, Sreenivasan V, Mulders JJ: Flavivirus West Nile (Sarafend) egress at the plasma membrane. Arch Virol 1994, 137:303–313.PubMedCrossRef 68.

Related posts:

  1. Nucleic Acids Res 1990,18(22):6531–6535 PubMedCrossRef 10 Yoshid
  2. Inside a third investigation, a mutant HIV one virus pseudotyped
  3. [44] Additionally, varicella zoster virus ORF61 interacts specifi
  4. Infect Immun 2002,70(8):4165–4176 PubMedCrossRef 3 Marches O, Co
  5. J Bacteriol

    2006,188(6):2290–2293 PubMedCrossRef 17 Mars
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>